z-logo
open-access-imgOpen Access
Genetic Variants in CCNB1 Associated With Differential Gene Transcription and Risk of Coronary In-Stent Restenosis
Author(s) -
Carlos Silvestre-Roig,
Patricia L. Fernández,
María Luisa Mansego,
Claudia M. van Tiel,
Rosa Viana,
Chiara Viviani Anselmi,
Gianluigi Condorelli,
Robbert J. de Winter,
Paula MartínFuentes,
María Solanas-Barca,
Fernando Civeira,
Amelia Focaccio,
Carlie J.M. de Vries,
Felipe Javier Chaves,
Vicente Andrés
Publication year - 2014
Publication title -
circulation cardiovascular genetics
Language(s) - English
Resource type - Journals
eISSN - 1942-325X
pISSN - 1942-3268
DOI - 10.1161/circgenetics.113.000305
Subject(s) - restenosis , medicine , odds ratio , stent , confidence interval , cohort , single nucleotide polymorphism , percutaneous coronary intervention , haplotype , angioplasty , oncology , cardiology , allele , myocardial infarction , genotype , biology , genetics , gene
The development of diagnostic tools to assess restenosis risk after stent deployment may enable the intervention to be tailored to the individual patient, for example, by targeting the use of drug-eluting stent to high-risk patients, with the goal of improving safety and reducing costs. The CCNB1 gene (encoding cyclin B1) positively regulates cell proliferation, a key component of in-stent restenosis. Therefore, we hypothesized that single-nucleotide polymorphisms in CCNB1 may serve as useful tools in risk stratification for in-stent restenosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom